MiNK Therapeutics, Inc. (INKT) stock
INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$8.84−0.45 (-4.79%)
Close on Nov 18, 2026Market cap $45.11MP/E –Yield –
MiNK Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
MiNK Therapeutics's price to book ratio was 11.2× on Jan 31, 2023.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 11.2× | −1.6 |
| 2022 | Dec 30, 2022 | 12.8× | – |
See a number that looks wrong?